Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hauschke

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Computer Methods and Programs in Biomedicine|June 1, 1995
Comment on: Updates of bioequivalence programs (including statistical power approximated by Student's t)D Hauschke
Journal of Biopharmaceutical Statistics|November 27, 1999
Approximate sample sizes for testing hypotheses about the ratio and difference of two meansM Kieser, D Hauschke
Journal of Biopharmaceutical Statistics|March 1, 1997
Individual bioequivalence--a European perspectiveV W Steinijans, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1990
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Statistics in Medicine|October 18, 2000
The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical companyD Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Controlled Clinical Trials|August 1, 1996
A note on conventional null hypothesis testing in active control equivalence studiesD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|May 1, 1996
Directional decision for a two-tailed alternativeD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|March 10, 2000
Identifying the maximum safe dose: a multiple testing approachL A Hothorn, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
A distribution-free procedure for the statistical analysis of bioequivalence studiesD Hauschke, V W Steinijans, E Diletti
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Computer Methods and Programs in Biomedicine|June 1, 1995
Comment on: Updates of bioequivalence programs (including statistical power approximated by Student's t)D Hauschke
Journal of Biopharmaceutical Statistics|November 27, 1999
Approximate sample sizes for testing hypotheses about the ratio and difference of two meansM Kieser, D Hauschke
Journal of Biopharmaceutical Statistics|March 1, 1997
Individual bioequivalence--a European perspectiveV W Steinijans, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1990
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Statistics in Medicine|October 18, 2000
The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical companyD Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Controlled Clinical Trials|August 1, 1996
A note on conventional null hypothesis testing in active control equivalence studiesD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|May 1, 1996
Directional decision for a two-tailed alternativeD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|March 10, 2000
Identifying the maximum safe dose: a multiple testing approachL A Hothorn, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
A distribution-free procedure for the statistical analysis of bioequivalence studiesD Hauschke, V W Steinijans, E Diletti
Pageof 5